Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Fever × Anti-Bacterial Agents × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Surgical Wound Infection 5 Neoplasms 4 Colorectal Neoplasms 4 Sepsis 2 Rectal Neoplasms 2 Pancreatic Neoplasms 2 Leukemia, Myeloid, Acute 2 Febrile Neutropenia 2 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Solitary Pulmonary Nodule 1 Skin Neoplasms 1 Pancreatic Fistula 1 Neutropenia 1 Neoplasms, Plasma Cell 1 Multiple Pulmonary Nodules 1 Multiple Myeloma 1 Multiple Endocrine Neoplasia Type 1 1 Melanoma 1 Lymphoma 1 Lung Neoplasms 1 Leukemia 1 Intestinal Neoplasms 1 Inflammation 1 Infections 1 Hematologic Neoplasms 1 Glioblastoma 1 Fever 1 Exanthema 1 Emergencies 1

Interventions

Vancomycin 4 pegfilgrastim 3 Cefepime 3 trametinib 2 dabrafenib 2 Piperacillin, Tazobactam Drug Combination 2 Filgrastim 2 Ciprofloxacin 2 Ceftazidime 2 ofatumumab 1 liposomal amphotericin B 1 ceftobiprole medocaril 1 Teicoplanin 1 Tazobactam 1 Surveys and Questionnaires 1 Ritonavir 1 Quality of Life 1 Povidone-Iodine 1 Piperacillin 1 Moxifloxacin 1 Metformin 1 Meropenem 1 Mannose-Binding Lectin 1 Levofloxacin 1 Lenalidomide 1 Itraconazole 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Granulocyte Colony-Stimulating Factor 1 Doxorubicin 1 Docetaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03768869 2021-04-27

Fever and Neutropenia in Pediatric Oncology Patients

University of Colorado, Denver

Phase 3 Withdrawn

Fever, Neoplasms, Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡